期刊档案
JCSM Rapid Communications
ISSN 2617-1619 · eISSN 2996-1394 · Wiley · United Kingdom
JCSM Rapid Communications 完全开放获取,APC 约 2,550 美元,出版商公布投稿到接收约 93 天,官网公布录用率 55%,2025 年发文 0 篇。
研究范围
研究范围与定位
JCSM Rapid Communications 由 Wiley 出版。按 OpenAlex 近年发文统计,该刊主要发表 Nutrition and Health in Aging、Muscle Physiology and Disorders、Frailty in Older Adults 等主题的论文,这 3 个主题约占 64.4%。(根据 OpenAlex 主题统计与中科院分区数据生成)
JCSM Communications considers articles and reviews which focus on the clinical and scientific aspects of the field and its incorporation into clinical practice. Academic rigour is of particular importance. The journal is focused on the bench to bedside approach, favouring studies and clinical observations which generate hypotheses and questions relevant to the patient and to the condition of cachexia and sarcopenia, as well as to body composition and its physiological and pathophysiological changes during the lifespan, and in response to different illnesses. The term cachexia describes involuntary weight loss that is observed in the course of many chronic diseases, and is one of the most debilitating and life-threatening aspects of various illnesses at advanced stages. Cachexia, wasting syndromes and sarcopenia are becoming a concerning challenge for an increasing number of patients, their relatives and the medical teams caring for them. JCSM Communications is of interest to all physicians, biochemists, biologists, dieticians, pharmacologists, and students dealing with cachexia, wasting and sarcopenia in various diseases. We welcome submissions with a translational focus from clinicians, researchers, policy makers and those working in industry. The scope of the journal includes, but is not limited to, the following topics Clinical and basic research studies into the alterations in body composition, particularly those affecting skeletal muscle, bone and fat tissue; Sarcopenia, i.e. loss of functional muscle mass without weight loss, as related to the ageing process, reduced physical performance, falls, and disability; Clinical trials to improve body composition or functional performance, also including exercise interventions; Clinical care of affected patients, such as those suffering from AIDS, cancer, chronic heart failure, chronic lung disease, liver cirrhosis, chronic kidney failure, rheumatoid arthritis, or sepsis; Functional importance of fat tissue and mechanisms leading to lipolysis; Mechanisms of muscle wasting; Potential therapeutic approaches; Diagnostic and assessment approaches involving researchers and clinicians seeking better screening and evaluation options and enhanced biomarkers through validated complementary investigations; Diseases associated with muscle loss such as neuromuscular disorders. At JCSM Communications, we aim to be a truly global forum for academically rigorous research, and we think that the best research should be publis
摘自期刊官网 Aims & Scope
主编 Stephan von Haehling出版商官网
编委会国家分布:未见中国大陆编委;主要国家 德国 12、意大利 4、巴西 4、美国 3、英国 3(共 33 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Nutrition and Health in AgingMedicine33%
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology26.2%
- Frailty in Older AdultsMedicine5.2%
- Body Composition Measurement TechniquesMedicine4.7%
- Clinical Nutrition and GastroenterologyNursing3.1%
- Dialysis and Renal Disease ManagementMedicine2.6%
- Cardiovascular and exercise physiologyMedicine2.6%
- Muscle metabolism and nutritionBiochemistry, Genetics and Molecular Biology2.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
ProQuest出版商官网
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 16OpenAlex ·
- i10-index
- 28OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年发文量(出版商公布) 2025
- 28出版商官网 ·
- 年下载量(出版商公布) 2025
- 44,899出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 102 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 0 | 0 | 97 |
| 2025 | 0 | 0 | 163 |
| 2024 | 0 | 0 | 155 |
| 2023 | 14 | 14 | 131 |
| 2022 | 20 | 20 | 125 |
| 2021 | 28 | 28 | 70 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
样本不足近 24 个月只有 6 篇文章登记了投稿与接收日期,不足以给出中位数
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
各来源数据
- 平均审稿速度(社区反馈)
- 10 WeeksLetPub ·
- 录用率(出版商公布) 2025
- 55%出版商官网 ·
- 投稿到首次决定 2025
- 48 天出版商官网 ·
- 投稿到接收 2025
- 93 天出版商官网 ·
- 接收到发表 2025
- 27 天出版商官网 ·
- 投稿到发表(期刊自报)
- 约 24 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,通常向作者收取文章处理费(APC)。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 2,550 / GBP 1,850 / EUR 2,310 | 有 | CC BY | |
| OpenAlex | USD 2,310 / EUR 1,980 / GBP 1,760 | — | — | |
| LetPub | USD 2,310 / GBP 1,760 / EUR 1,980 | 有 | — | |
| 出版商官网 | 有,金额未公布 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点4 项,摘自作者指南
- 摘要
- 150–400 词
- 关键词
- ≤ 7 个
- 正文篇幅
- ≤ 5,000 词
- 参考文献格式
- Vancouver 格式
接收的文章类型10 种
- case reportArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- commentaryArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- correspondenceArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- editorialArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- letter to the editorArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- opinionArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- original articleArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- perspectiveArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
- rapid/short communicationRapid/Short Communication Preliminary findings of research in progress 2500 Yes, Structured Data Availability Statement IRB Statement未说明篇幅
- short communicationArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Reports of new research findings or conceptual analyses that make a…未说明篇幅
官网政策摘录AI 使用、作者资格、数据可用性、许可与版权、开放获取、同行评审、查重、预印本
- AI 使用 AI Policy
该期刊规定,人工智能生成内容(AIGC)工具(如ChatGPT等基于大语言模型的工具)不能被视为能够在没有人类作者指导的情况下发起原创研究,也不能对已发表作品或研究设计负责,且不具备法律地位或持有、转让版权的能力,因此依据COPE关于AI工具的立场声明,这些工具不能承担作者角色,也不能被列为文章作者。 模型中文摘要
Artificial Intelligence Generated Content (AIGC) tools — such as ChatGPT and others based on large language models (LLMs) — cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section)…
原文 ↗出版商官网 ·- 作者资格 Authorship
该期刊要求所有列名作者应对稿件作出实质性贡献并同意最终提交版本;每篇稿件投稿只允许一名通讯作者,通讯作者是期刊办公室的主要联系人,也是编辑评审过程中唯一可访问或修改稿件的作者;稿件被接受后,作者可选择指定最多两名额外的可被读者联系的联系人。 模型中文摘要
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria. The journal allows for only one corresponding author per manuscript submission. The corresponding author serves as the main contact for the journal office and is the sole author who can access…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing and Data Availability
对于2024年7月之后的投稿,该期刊鼓励数据共享,作者可查阅Wiley的数据共享政策,以查看并选择适合其投稿的数据可用性声明。 模型中文摘要
For submissions after July 2024 this journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
原文 ↗出版商官网 ·- 许可与版权 Reproduction of Copyright Material
该期刊规定,如稿件中包含第三方版权作品的摘录,必须在稿件中注明所有来源,至少提供标题和作者;通讯作者负责从原出版商处获得以印刷及其他媒体形式复制该材料的书面许可,并应要求向Wiley提供该许可。 模型中文摘要
If excerpts from copyrighted works owned by third parties are included, all sources must be credited within the manuscript. At minimum, the title and author should be provided. The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon requ…
原文 ↗出版商官网 ·- 开放获取 Open Access
该期刊为金色开放获取期刊,稿件若被接受并发表将需支付文章处理费(APC);作者可通过机构、资助方或国家减免政策了解是否有资格获得减免或折扣。 模型中文摘要
This journal is a Gold Open Access journal. Submissions will be subject to an APC if accepted and published in the journal. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page here.
原文 ↗出版商官网 ·- 同行评审 1. Submission and Peer Review Process
Single-anonymized peer review; Associate Editor engages at least two anonymous reviewers; papers sent to review only if Editor-in-Chief determines quality/relevance requirements met; in-house submissions handled unaffiliated and monitored for bias. 模型摘要
Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made online via the Research Exchange submission portal: https://authors.wiley.com/journal/rco2. You may check the status of your submission at any time by logging on to authors.wiley.com and clicking the "My Submissions" button. For technical help with the submission system, please…
原文 ↗出版商官网 ·- 查重 IThenticate CrossCheck
该期刊使用iThenticate的CrossCheck软件检测投稿稿件中重叠和相似文本的情况。 模型中文摘要
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines.
原文 ↗出版商官网 ·- 预印本 Preprint Policy
该期刊接受曾在预印本服务器上发表过的文章,会考虑评审此前已作为预印本提供的稿件;作者需更新任何预发表版本并附上指向最终发表文章的链接,也可在发表后立即发布文章的最终发表版本。 模型中文摘要
Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers. JCSM Communications will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Wiley
- 出版国家或地区
- United Kingdom
- 出版语言
- English
- ISSN
- 2617-1619
- 电子版 ISSN
- 2996-1394
- 官网最新一期
- Volume 9, Issue 2(2026 年 12 月)
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 JCSM Rapid Communications 的常见问题
JCSM Rapid Communications 的审稿周期多长?
出版商公布的投稿到接收时间约为 93 天;投稿社区反馈的平均审稿速度为约 10 周;期刊官网公布的录用率为 55%(2025)。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
JCSM Rapid Communications 的投稿格式要求是什么?
据期刊作者指南:摘要:150–400 词;关键词:≤ 7 个;正文篇幅:≤ 5,000 词;参考文献格式:Vancouver 格式。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
JCSM Rapid Communications 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 33 位编委中,没有中国大陆学者;人数最多的国家是 德国(12 位)、意大利(4 位)、巴西(4 位)。统计按编委会页面列出的机构国家计,仅供参考。
JCSM Rapid Communications 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,JCSM Rapid Communications 被 DOAJ 收录。
JCSM Rapid Communications 是开放获取期刊吗?版面费多少?
JCSM Rapid Communications 为完全开放获取。APC 约 2,550 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。